-transparent.png){kind=logo}
The addition of MC16 tumor cells (a prostaglandin E2-producing cell line induced in C57BL/6J mice by methylcholanthrene) to cultures of cells to sheep red blood cells. This inhibition can be blocked by adding to the cultures prostaglandin synthetase inhibitors, such as indomethacin, flufenamic acid and aspirin. These MC16 tumor cells are also immunosuppressive in vivo. Mice bearing the syngeneic MC16 tumor become unresponsive to sheep red blood cells as the tumor grows. As in the in vitro test system, inhibitors of prostaglandin synthetases seem to block the immunosuppressive activity of MC16 cells in vivo since tumor-bearing mice, treated therapeutically with indomethacin, responded normally in their production of antibody to sheep red blood cells.
K D Grinwich, and
O J Plescia
January 1986,
Experimental cell biology,
K D Grinwich, and
O J Plescia
April 1981,
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
K D Grinwich, and
O J Plescia
May 2014,
Nature medicine,
K D Grinwich, and
O J Plescia
November 1981,
La Clinica terapeutica,
K D Grinwich, and
O J Plescia
January 2014,
Immunotherapy,
K D Grinwich, and
O J Plescia
July 1977,
Transactions of the ophthalmological societies of the United Kingdom,
K D Grinwich, and
O J Plescia
January 1981,
Progress in lipid research,
K D Grinwich, and
O J Plescia
January 1978,
Gynakologische Rundschau,
K D Grinwich, and
O J Plescia
January 1986,
Anticancer research,
K D Grinwich, and
O J Plescia
January 2007,
Clinical cancer research : an official journal of the American Association for Cancer Research,
